| Product Code: ETC12125071 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In the Indonesia exeter erlotinib hydrochloride tablet market, the import trend showed a notable decline from 2023 to 2024, with a growth rate of -48.45%. The compound annual growth rate (CAGR) for the period 2020-2024 stood at -28.01%. This significant decrease in imports could be attributed to shifting demand patterns or changes in market dynamics impacting trade flows.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, 2022 & 2032F |
3.3 Indonesia Exeter Erlotinib Hydrochloride Tablet Market - Industry Life Cycle |
3.4 Indonesia Exeter Erlotinib Hydrochloride Tablet Market - Porter's Five Forces |
3.5 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Dosage Form, 2022 & 2032F |
3.7 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Therapeutic Class, 2022 & 2032F |
3.8 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Indonesia |
4.2.2 Growing awareness about the effectiveness of erlotinib hydrochloride tablets in treating lung cancer |
4.2.3 Rise in healthcare expenditure and investments in oncology treatments in Indonesia |
4.3 Market Restraints |
4.3.1 High cost associated with erlotinib hydrochloride tablets |
4.3.2 Stringent regulatory requirements for drug approval in Indonesia |
4.3.3 Competition from alternative treatments for lung cancer |
5 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Trends |
6 Indonesia Exeter Erlotinib Hydrochloride Tablet Market, By Types |
6.1 Indonesia Exeter Erlotinib Hydrochloride Tablet Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib Tablets, 2022 - 2032F |
6.1.4 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 100mg Tablets, 2022 - 2032F |
6.1.5 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 150mg Tablets, 2022 - 2032F |
6.1.6 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 25mg Tablets, 2022 - 2032F |
6.2 Indonesia Exeter Erlotinib Hydrochloride Tablet Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Oral Tablets, 2022 - 2032F |
6.2.3 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 100mg Tablets, 2022 - 2032F |
6.2.4 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 150mg Tablets, 2022 - 2032F |
6.2.5 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 25mg Tablets, 2022 - 2032F |
6.3 Indonesia Exeter Erlotinib Hydrochloride Tablet Market, By Therapeutic Class |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By EGFR Inhibitors, 2022 - 2032F |
6.3.3 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Chemotherapy Drugs, 2022 - 2032F |
6.3.4 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Anticancer Medications, 2022 - 2032F |
6.3.5 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Chemotherapy Alternatives, 2022 - 2032F |
6.4 Indonesia Exeter Erlotinib Hydrochloride Tablet Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Cancer Patients, 2022 - 2032F |
6.4.3 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Non-small Cell Lung Cancer, 2022 - 2032F |
6.4.4 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Pancreatic Cancer Patients, 2022 - 2032F |
6.4.5 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Patients with Limited Treatment Options, 2022 - 2032F |
7 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Import-Export Trade Statistics |
7.1 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Export to Major Countries |
7.2 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Imports from Major Countries |
8 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Key Performance Indicators |
8.1 Number of new lung cancer cases diagnosed annually in Indonesia |
8.2 Adoption rate of erlotinib hydrochloride tablets among oncologists in Indonesia |
8.3 Patient satisfaction and reported outcomes with the use of erlotinib hydrochloride tablets in lung cancer treatment |
9 Indonesia Exeter Erlotinib Hydrochloride Tablet Market - Opportunity Assessment |
9.1 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Dosage Form, 2022 & 2032F |
9.3 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Therapeutic Class, 2022 & 2032F |
9.4 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Indonesia Exeter Erlotinib Hydrochloride Tablet Market - Competitive Landscape |
10.1 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Revenue Share, By Companies, 2025 |
10.2 Indonesia Exeter Erlotinib Hydrochloride Tablet Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here